7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Association Between Early Postoperative Acetaminophen Exposure and Acute Kidney Injury in Pediatric Patients Undergoing Cardiac Surgery

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          <div class="section"> <a class="named-anchor" id="ab-poi180016-1"> <!-- named anchor --> </a> <h5 class="section-title" id="d1982176e415">Question</h5> <p id="d1982176e417">Does early postoperative acetaminophen exposure reduce the incidence of acute kidney injury in children who undergo cardiac surgery? </p> </div><div class="section"> <a class="named-anchor" id="ab-poi180016-2"> <!-- named anchor --> </a> <h5 class="section-title" id="d1982176e420">Findings</h5> <p id="d1982176e422">In this cohort study, acetaminophen exposure in the first postoperative 48 hours was associated with a lower rate of acute kidney injury in pediatric patients who underwent cardiac surgery in primary and validation cohorts from 2 tertiary referral children’s hospitals. </p> </div><div class="section"> <a class="named-anchor" id="ab-poi180016-3"> <!-- named anchor --> </a> <h5 class="section-title" id="d1982176e425">Meaning</h5> <p id="d1982176e427">Postoperative use of acetaminophen may protect pediatric cardiac surgery patients from acute kidney injury. </p> </div><div class="section"> <a class="named-anchor" id="ab-poi180016-4"> <!-- named anchor --> </a> <h5 class="section-title" id="d1982176e431">Importance</h5> <p id="d1982176e433">Acute kidney injury (AKI) is a common and serious complication for pediatric cardiac surgery patients associated with increased morbidity, mortality, and length of stay. Current strategies focus on risk reduction and early identification because there are no known preventive or therapeutic agents. Cardiac surgery and cardiopulmonary bypass lyse erythrocytes, releasing free hemoglobin and contributing to oxidative injury. Acetaminophen may prevent AKI by reducing the oxidation state of free hemoglobin. </p> </div><div class="section"> <a class="named-anchor" id="ab-poi180016-5"> <!-- named anchor --> </a> <h5 class="section-title" id="d1982176e436">Objective</h5> <p id="d1982176e438">To test the hypothesis that early postoperative acetaminophen exposure is associated with reduced risk of AKI in pediatric patients undergoing cardiac surgery. </p> </div><div class="section"> <a class="named-anchor" id="ab-poi180016-6"> <!-- named anchor --> </a> <h5 class="section-title" id="d1982176e441">Design, Setting, and Participants</h5> <p id="d1982176e443">In this retrospective cohort study, the setting was 2 tertiary referral children’s hospitals. The primary and validation cohorts included children older than 28 days admitted for cardiac surgery between July 1, 2008, and June 1, 2016. Exclusion criteria were postoperative extracorporeal membrane oxygenation and inadequate serum creatinine measurements to determine AKI status. </p> </div><div class="section"> <a class="named-anchor" id="ab-poi180016-7"> <!-- named anchor --> </a> <h5 class="section-title" id="d1982176e446">Exposures</h5> <p id="d1982176e448">Acetaminophen exposure in the first 48 postoperative hours.</p> </div><div class="section"> <a class="named-anchor" id="ab-poi180016-8"> <!-- named anchor --> </a> <h5 class="section-title" id="d1982176e451">Main Outcomes and Measures</h5> <p id="d1982176e453">Acute kidney injury based on Kidney Disease: Improving Global Outcomes serum creatinine criteria (increase by ≥0.3 mg/dL from baseline or at least 1.5-fold more than the baseline [to convert to micromoles per liter, multiply by 88.4]) in the first postoperative week. </p> </div><div class="section"> <a class="named-anchor" id="ab-poi180016-9"> <!-- named anchor --> </a> <h5 class="section-title" id="d1982176e456">Results</h5> <p id="d1982176e458">The primary cohort (n = 666) had a median age of 6.5 (interquartile range [IQR], 3.9-44.7) months, and 341 (51.2%) had AKI. In unadjusted analyses, those with AKI had lower median acetaminophen doses than those without AKI (47 [IQR, 16-88] vs 78 [IQR, 43-104] mg/kg, <i>P</i> &lt; .001). In logistic regression analysis adjusting for age, cardiopulmonary bypass time, red blood cell distribution width, postoperative hypotension, nephrotoxin exposure, and Risk Adjustment for Congenital Heart Surgery score, acetaminophen exposure was protective against postoperative AKI (odds ratio, 0.86 [95% CI, 0.82-0.90] per each additional 10 mg/kg). Findings were replicated in the validation cohort (n = 333), who had a median age of 14.1 (IQR, 3.9-158.2) months, and 162 (48.6%) had AKI. Acetaminophen doses were 60 (95% CI, 40-87) mg/kg in those with AKI vs 70 (95% CI, 45-94) mg/kg in those without AKI ( <i>P</i> = .03), with an adjusted odds ratio of 0.91 (95% CI, 0.84-0.99) for each additional 10 mg/kg. </p> </div><div class="section"> <a class="named-anchor" id="ab-poi180016-10"> <!-- named anchor --> </a> <h5 class="section-title" id="d1982176e467">Conclusions and Relevance</h5> <p id="d1982176e469">These results indicate that early postoperative acetaminophen exposure may be associated with a lower rate of AKI in pediatric patients who undergo cardiac surgery. Further analysis to validate these findings, potentially through a prospective, randomized trial, may establish acetaminophen as a preventive agent for AKI. </p> </div><p class="first" id="d1982176e472">This study tests the hypothesis that early postoperative acetaminophen exposure is associated with reduced risk of acute kidney injury in pediatric patients undergoing cardiac surgery. </p>

          Related collections

          Most cited references30

          • Record: found
          • Abstract: found
          • Article: not found

          Serum creatinine as stratified in the RIFLE score for acute kidney injury is associated with mortality and length of stay for children in the pediatric intensive care unit.

          To evaluate the ability of the RIFLE criteria to characterize acute kidney injury in critically ill children. Retrospective analysis of prospectively collected clinical data. Multidisciplinary, tertiary care, 20-bed pediatric intensive care unit. All 3396 admissions between July 2003 and March 2007. None. A RIFLE score was calculated for each patient based on percent change of serum creatinine from baseline (risk = serum creatinine x1.5; injury = serum creatinine x2; failure = serum creatinine x3). Primary outcome measures were mortality and intensive care unit length of stay. Logistic and linear regressions were performed to control for potential confounders and determine the association between RIFLE score and mortality and length of stay, respectively.One hundred ninety-four (5.7%) patients had some degree of acute kidney injury at the time of admission, and 339 (10%) patients had acute kidney injury develop during the pediatric intensive care unit course. Almost half of all patients with acute kidney injury had their maximum RIFLE score within 24 hrs of intensive care unit admission, and approximately 75% achieved their maximum RIFLE score by the seventh intensive care unit day. After regression analysis, any acute kidney injury on admission and any development of or worsening of acute kidney injury during the pediatric intensive care unit stay were independently associated with increased mortality, with the odds of mortality increasing with each grade increase in RIFLE score (p < .01). Patients with acute kidney injury at the time of admission had a length of stay twice that of those with normal renal function, and those who had any acute kidney injury develop during the pediatric intensive care unit course had a four-fold increase in pediatric intensive care unit length of stay. Also, other than being admitted with RIFLE risk score, an independent relationship between any acute kidney injury at the time of pediatric intensive care unit admission, any acute kidney injury present during the pediatric intensive care unit course, or any worsening RIFLE scores during the pediatric intensive care unit course and increased pediatric intensive care unit length of stay were identified after controlling for the same high-risk covariates (p < .01). RIFLE criteria serves well to describe acute kidney injury in critically ill pediatric patients.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Validation of the KDIGO acute kidney injury criteria in a pediatric critical care population.

            Acute kidney injury (AKI) occurs commonly in critically ill children and has been associated with increased mortality of up to 50 %. The Kidney Disease: Improving Global Outcomes (KDIGO) AKI working group has proposed a standardized definition of AKI. Utilizing routinely available clinical data, we evaluated the KDIGO AKI criteria and the relationship of AKI with relevant outcomes in a single center tertiary pediatric intensive care (PICU) and cardiac intensive care unit (CICU) population.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Novel biomarkers, oxidative stress, and the role of labile iron toxicity in cardiopulmonary bypass-associated acute kidney injury.

              Cardiac surgery-associated acute kidney injury (AKI) is common and carries a poor prognosis. Hemodynamic and inflammatory factors and the release of labile iron, contributing to oxidation from reactive oxygen species are among the major determinants of cardiac surgery-associated AKI. The diagnosis of AKI is typically delayed because of the limitations of currently used clinical biomarkers indicating loss of renal function. However, several novel renal biomarkers, which predict AKI or protection from AKI after cardiopulmonary bypass (CPB), have been identified as early markers of kidney injury. In this state-of-the-art review, the authors analyze the pathophysiological implications of recent findings regarding novel renal biomarkers in relation to CPB-associated AKI. Neutrophil gelatinase-associated lipocalin, liver-type fatty acid-binding protein, and alpha-1 microglobulin predict the development of CPB-associated AKI, while hepcidin isoforms appear to predict protection from it, and these biomarkers are involved in iron metabolism. Neutrophil gelatinase-associated lipocalin participates in local iron transport. Liver-type fatty acid-binding protein and alpha-1 microglobulin function as high-affinity heme-binding proteins in different species, while hepcidin is central to iron sequestration and when increased in the urine appears to protect from CPB-associated AKI. Free iron-related, reactive oxygen species-mediated kidney injury appears to be the unifying pathophysiological connection for these biomarkers. Such novel findings on renal tubular biomarkers were further combined with other lines of evidence related to hemolysis during CPB, the associated excess of free heme and iron, knowledge of the effect of free iron on renal tubular cells, and recent trial evidence targeting free iron-mediated mechanisms of AKI. Novel biomarkers point toward free iron-mediated toxicity to be an important mechanism of AKI in patients receiving cardiac surgery with CPB. Copyright 2010 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
                Bookmark

                Author and article information

                Journal
                JAMA Pediatrics
                JAMA Pediatr
                American Medical Association (AMA)
                2168-6203
                July 01 2018
                July 01 2018
                : 172
                : 7
                : 655
                Affiliations
                [1 ]Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, Tennessee
                [2 ]Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee
                [3 ]Department of Pediatrics, Duke University School of Medicine, Durham, North Carolina
                [4 ]Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, Tennessee
                [5 ]Cardiovascular Perfusion Technology Program, Vanderbilt University Medical Center, Nashville, Tennessee
                [6 ]Department of Biomedical Informatics, Vanderbilt University School of Medicine, Nashville, Tennessee
                [7 ]Department of Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee
                [8 ]Department of Pathology, Microbiology, and Immunology, Vanderbilt University School of Medicine, Nashville, Tennessee
                Article
                10.1001/jamapediatrics.2018.0614
                6110290
                29799947
                2eeac46d-84c1-4deb-9c03-82e73372b6b5
                © 2018
                History

                Comments

                Comment on this article